This is an excellent explanation of how important the LEAP technology is, and how it has overcome the global bottleneck in exosome purification/isolation. This sort of news will slowly digest in the market, and it should start to pop up on a few “radars” around the world in the coming weeks/months. The first human trials by EX1 are due to start in the next few months.
